Usage: All products on this site are for In-Vitro Research, Development use only. Products are Not for Human consumption of any kind.
Name: AOD-9604, AOD9604, AOD 9604,
CAS No.: 221231-10-3
Other Names: peptide fragment of the C-terminus of human growth hormone (Tyr-hGH177-191)
Brand Name: UNEWLIFE
Grade: Pharm Medicine Grade
MFG: Fresh batch in 2023
Shelf Life: 2 years of proper storage
Appearance: White Powder
Test Reports: MS/COA/HPLC
Packing: 2mg/vial,10 vials/Box
Label: without labels, can be OEM/ODM customized.
Box: white carton box, that can be OEM/ODM customized.
Shipping: by express or post.
Feedback: How do they say? More reviews here
For more questions, check the answers here: FAQ
AOD-9604: FAT-BURNING PEPTIDE
AOD-9604 is a modified form Growth Hormone which is a 191 amino acid peptide. The last 15 amino acids (177-191) of the Growth Hormone polypeptide have been reproduced as a specific peptide and is called GH Frag 177-191 or AOD-9604.
AOD-9604 is one of the best peptides for weight loss. It also has additional benefits that can help with fat reduction, better metabolism and more.
BENEFITS OF AOD-9604:
- Reduces body fat
- Triggers fat release from obese fat cells predominantly more than lean ones
- Mimics the way natural growth hormone regulates fat metabolism
- No adverse effects on blood sugar or growth
- AOD-9604 stimulates lipolysis
- Inhibits lipogenesis that’s the transformation of non-fatty foods into body fat
- AOD-9604 has been shown to have very favorable cartilage repair and regenerative properties, especially when paired with peptide BPC 157.
AOD-9604 (Advanced Obesity Drug) was originally developed by Professor Frank Ng at Monash University in Australia in the 1990s, with the intent of finding an anti-obesity drug that had the fat-burning effects of human growth hormone (HGH) without the muscle-building effect.
Other recent findings have shown, in addition to its fat loss properties, AOD-9604 processes many other regenerative properties associated with growth hormone. Currently, trials are underway to show the application of AOD-9604 in osteoarthritis, hypercholesterolemia, bone and cartilage repair.
Results of oral glucose tolerance test demonstrated that, in contrast with hGH, AOD-9604 has no negative effect on carbohydrate metabolism. There were no anti-AOD-9604 antibodies detected in any of the patients selected for antibody assay. In none of the studies did a withdrawal or serious adverse event occur related to intake of AOD-9604.
AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. AOD-9604 did not result in any of the adverse effects associated with full-length hGH treatment. AOD-9604 has an excellent safety profile, recently obtaining Human GRAS status in the USA.